Protein A Resins Market to observe remarkable push over 2018-2024| Key Players: Danaher Corporation, Bio-Rad Laboratories, GenScript, Novasep

The Protein A Resins Market is set to exceed USD 900 million by 2024; according to a new research report by Global Market Insights. Demand for monoclonal antibodies is increasing rapidly from past few years due to its wide range of applications in the management of chronic diseases such as cancer. In response to increasing demand, manufacturers are optimizing their production capacities and launching new plants for large scale production of monoclonal antibodies. Several monoclonal antibodies have already been approved while many are still in the late phase of clinical trials. Increasing production of monoclonal antibodies will escalate the need of protein A resins for antibody purification on large scale impacting industry growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1146

Ongoing drug developments and drug related research will boost the demand for protein A resin market over forecast timeframe. The pharmaceutical manufacturers are increasingly putting efforts for the development of better biologics. Increasing healthcare expenditure, awareness and adoption rates of novel therapies and health infrastructure will render significant positive impact on industry growth. However, high cost of resins lining the chromatography column will impede the business growth.

Protein A resins industry mainly finds its application in two sectors- antibody purification, and immunoprecipitation. Protein A resins market size in antibody purification application is slated to witness a substantial growth in future, with an expected revenue share of USD 700 million by 2024, driven by the increasing diagnostic application of recombinant and monoclonal antibodies.Immunoprecipitation industry held a share of 20% of the overall market in 2015, and is anticipated to grow an annual rate of 8% over the period 2016- 2024.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Danaher Corporation
• Bio-Rad Laboratories
• GenScript
• Novasep
• Purolite Life Sciences
• Expedeon
• GE Healthcare
• Repligen Corporation
• Sigma-Aldrich
• Takara Bio Inc.
• Thermo Fisher Scientific
• Agarose Bead Technologies ABT
• EMD Millipore
• Tosoh Bioscience, Inc.

Biopharmaceutical firms and Contract research organizations are the major end users of protein A resins industry. Biopharmaceutical companies accounted for a share of 75% of resins market in 2015, and is expected to surpass USD 680 million by 2024. Protein A resins market is also projected to grow significantly owing to its increasing adaption by Contract research organizations (CROs). It is estimated to have a revenue share of USD 130 million at an annual growth rate of 8.1% over the period 2016 to 2024.

The globally renowned pharmaceutical company Teva has created quite some buzz in market lately, claiming that it has increased the life of its Protein A resin thereby reducing costs of manufacturing of monoclonal antibodies. The company has reportedly tweaked its cleaning-in-place (CIP) and sterilization-in-place (SIP) processes that enable a longer life span for its MabSelect SuRe Protein A resins. According to industry experts, increased life of Protein A resin can have direct cost advantage, which in this case accounts for as much as 30% of the total cost of making a monoclonal antibody.

Glass or silica gel-based matrix segment of protein A resins market is forecasted to witness healthy growth over the forecast timeframe due to improved durability, mechanical strength and ability to incorporate high absorption of metallic dopants. However, agarose-based matrix type accounted for largest revenue share in 2017 and is expected to dominate the industry throughout the forecast period. Suitable pH range, good resolution at minimum time, high flow rate makes these types of beads perfect for process scale practices.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1146

U.S. accounted for largest regional share in 2017 due to robust research and development in the field of drug discovery and ongoing inflow of approved monoclonal antibodies in the protein A resins market. Technological advancements coupled with the availability of funding for research on novel therapies will further render significant positive impact growth. Japans market dominated the Asia Pacific region in 2017 due to increasing demand for novel therapies to combat with chronic diseases. Well-developed pharmaceutical sector and healthcare infrastructure, and ongoing research and development activities will augment Japanese market.

Protein A Resins Market by Application

Immunoprecipitation
Antibody Purification

Protein A Resins Market by Product

Natural Protein A
Recombinant Protein A

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.